Skip to main content
. 2017 Dec 15;9(8):7844–7858. doi: 10.18632/oncotarget.23541

Figure 1. Patterns of mutations in key signaling pathway genes were consistent with previously described traits of primary GBM.

Figure 1

OncoPrint summarizing the non-synonymous and splice site variants detected by targeted deep sequencing in both diagnostic (open circles) and relapse (closed circles) specimens for each of the 21 patients. Specimens with methylation of MGMT are noted in red.